Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study (Q34526245)
scientific article
Language:
Current Data About Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
(P31) (Q13442814)
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P304) 239-247
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P478) 17
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P577) Sunday, September 1, 2002
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P921) (Q269829)

(Q42844)
(P887)

(P1433) (Q15751307)
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P1476) "Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study" (language: en)
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

(P2093) Lôo H
(P1545) 1
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

Hale A
(P1545) 2
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

D'haenen H
(P1545) 3
(P248)
(P698) 12177586
(P813) Wednesday, August 2, 2017

other details
description scientific article

External Links
(P356) 10.1097/00004850-200209000-00004
(P698) 12177586